Intrinsic Value of S&P & Nasdaq Contact Us

Zai Lab Limited ZLAB NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • CN • USD

SharesGrow Score
61/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$35.00
+59.4%

Zai Lab Limited (ZLAB) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 9 Buy, 2 Hold.

The consensus price target is $35.00, representing an upside of 59.4% from the current price $21.96.

Analysts estimate Earnings Per Share (EPS) of $-0.39 and revenue of $0.06B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-2.60 vs est $-0.39 (missed -562.4%). 2025: actual $-1.60 vs est $-0.26 (missed -522.9%). Analyst accuracy: 16%.

ZLAB Stock — 12-Month Price Forecast

$35.00
▲ +59.38% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for Zai Lab Limited, the price target is $35.00.
The average price target represents a +59.38% change from the last price of $21.96.

ZLAB Analyst Ratings

Buy
11
Ratings
9 Buy
2 Hold
Based on 11 analysts giving stock ratings to Zai Lab Limited in the past 3 months
Rating breakdown
Buy
9 82%
Hold
2 18%
82%
Buy
9 analysts
18%
Hold
2 analysts
0%
Sell
0 analysts

EPS Estimates — ZLAB

16%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$2.60 vs Est –$0.39 ▼ 84.9% off
2025 Actual –$1.60 vs Est –$0.26 ▼ 83.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — ZLAB

15%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.399B vs Est $0.058B ▲ 85.6% off
2025 Actual $0.460B vs Est $0.067B ▲ 85.3% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message